Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA)
CUSIP: 925050106
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Ordinary Shares, nominal value 0.05 GBP per share
- Shares outstanding
- 84,213,667
- Total 13F shares
- 8,407,168
- Share change
- -288,310
- Total reported value
- $78,583,000
- Price per share
- $9.05
- Number of holders
- 17
- Value change
- -$2,815,272
- Number of buys
- 3
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 925050106?
CUSIP 925050106 identifies VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 925050106:
Top shareholders of VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q4 2018
As of 31 Dec 2018,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,407,168 shares.
The largest 10 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, Abingworth LLP, venBio Partners LLC, venBio Partners L.P., Novo Holdings A/S, Aisling Capital Management LP, Tekla Capital Management LLC, and Foresite Capital Management III, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
14
Q4 2018 holders
17
Holder diff
3
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.